Sam Brusco, Associate Editor01.29.24
Aurora Spine has received U.S. Patent No. 11,832,853 entitled “Hybrid Radiolucent Surgical Operating Tube”.
The company’s Ghost Tube was designed for superior anchoring with a translucent thermoplastic body and non-slipping, titanium anchors so minimally invasive surgical access will remain stationary. This supports surgical preparation tools without blocking X-ray visualization during surgery.
The patent describes a radiolucent tube that allows X-ray visualization of objects passing through it. It has a proximal end with and opening and distal end with an opening. It has one or more mounts on its distal end to attach removable, anchoring tips, as well as one or more removable anchoring tips attached to the distal end with one or more mounts.
"Aurora Spine has created several disruptive technologies in the past 12 years,” said Trent Northcutt, president and CEO of Aurora Spine. " This newly received patent of our GhostTube that supports our recently launched SiLO TFX SI Fusion System will allow us to support delivery of the SiLO TFX implant and create several new radiolucent tools for future product lines that require a steady and reliable bone anchoring with a repeatable clinical outcome for each patient requiring joint stabilization surgery.”
The company began full commercial rollout of SiLO TFX in September 2023 after completing its first surgeries earlier in the year. It’s indicated for sacroiliac (SI) joint fusion for conditions including sacroiliac joint disruptions and degenerative sacroiliitis.
Laszlo Garamszegi, chief technology officer of Aurora Spine, added “We are very excited to receive another United States patent that bolsters our growing product and intellectual property portfolio. Aurora will continue being disruptive and innovative by looking at ways to efficiently deliver our products and create and improve new treatment options to improve patient care and overall patient outcomes.”
The company’s Ghost Tube was designed for superior anchoring with a translucent thermoplastic body and non-slipping, titanium anchors so minimally invasive surgical access will remain stationary. This supports surgical preparation tools without blocking X-ray visualization during surgery.
The patent describes a radiolucent tube that allows X-ray visualization of objects passing through it. It has a proximal end with and opening and distal end with an opening. It has one or more mounts on its distal end to attach removable, anchoring tips, as well as one or more removable anchoring tips attached to the distal end with one or more mounts.
"Aurora Spine has created several disruptive technologies in the past 12 years,” said Trent Northcutt, president and CEO of Aurora Spine. " This newly received patent of our GhostTube that supports our recently launched SiLO TFX SI Fusion System will allow us to support delivery of the SiLO TFX implant and create several new radiolucent tools for future product lines that require a steady and reliable bone anchoring with a repeatable clinical outcome for each patient requiring joint stabilization surgery.”
The company began full commercial rollout of SiLO TFX in September 2023 after completing its first surgeries earlier in the year. It’s indicated for sacroiliac (SI) joint fusion for conditions including sacroiliac joint disruptions and degenerative sacroiliitis.
Laszlo Garamszegi, chief technology officer of Aurora Spine, added “We are very excited to receive another United States patent that bolsters our growing product and intellectual property portfolio. Aurora will continue being disruptive and innovative by looking at ways to efficiently deliver our products and create and improve new treatment options to improve patient care and overall patient outcomes.”